Cancer drug price caps: Balancing affordability and quality of care
The Supreme Court of India raised concerns about excessive mark-ups on cancer drugs, highlighting the need for price caps to ensure affordability. This issue affects access to quality care for patients, prompting a discussion on balancing costs with treatment standards. Stakeholders are urged to address these concerns to improve healthcare outcomes in the country.